---
figid: PMC4559532__15_001_cazalyf3
figlink: /pmc/articles/PMC4559532/figure/f3-15_001_cazaly/
number: F3
caption: Advances in epigenetic therapy. Epigenetic modifiers and modifications provide
  targets for therapeutic intervention in disease. (A) Two histone deacetylase inhibitors
  are FDA approved for treatment of subtypes of leukemia. (B) Inhibitors of a range
  of epigenetic modifiers, including histone methyltransferase enzymes, are in preclinical
  trials. (C) DNA demethylating agents decrease genomic methylation, restoring aberrantly
  silenced gene expression by acting directly to inhibit methylating enzymes or as
  cytidine analogs are incorporated into nucleic acid of dividing cells, preventing
  methylation. (D) Cytidine analogs have the secondary effect of activating the p53
  damage pathway and inducing apoptosis.
pmcid: PMC4559532
papertitle: 'Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease.'
reftext: Emma Cazaly, et al. Mol Med. 2015;21(1):400-409.
pmc_ranked_result_index: '98431'
pathway_score: 0.8647894
filename: 15_001_cazalyf3.jpg
figtitle: Advances in epigenetic therapy
year: '2015'
organisms:
- Homo sapiens
ndex: 29ec0d84-df1e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4559532__15_001_cazalyf3.html
  '@type': Dataset
  description: Advances in epigenetic therapy. Epigenetic modifiers and modifications
    provide targets for therapeutic intervention in disease. (A) Two histone deacetylase
    inhibitors are FDA approved for treatment of subtypes of leukemia. (B) Inhibitors
    of a range of epigenetic modifiers, including histone methyltransferase enzymes,
    are in preclinical trials. (C) DNA demethylating agents decrease genomic methylation,
    restoring aberrantly silenced gene expression by acting directly to inhibit methylating
    enzymes or as cytidine analogs are incorporated into nucleic acid of dividing
    cells, preventing methylation. (D) Cytidine analogs have the secondary effect
    of activating the p53 damage pathway and inducing apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SIRT2
  - HDAC7
  - SIRT5
  - TSPYL2
  - HDAC5
  - HDAC6
  - SIRT6
  - SIRT4
  - SIRT3
  - HDAC3
  - PAFAH1B1
  - SIRT7
  - HDAC11
  - DNMT1
  - HDAC9
  - HDAC8
  - HDAC4
  - HDAC10
  - EZH2
  - HDAC2
  - TP53
  - SIRT1
  - HDAC1
  - Romidepsin
  - 5-Azacitidine
  - Cytidine
  - 'Cytosine  Me '
  - Guanine
  - Hydralazine
genes:
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: CTCL)
  symbol: CTCL
  source: hgnc_alias_symbol
  hgnc_symbol: TSPYL2
  entrez: '64061'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: MDS)
  symbol: MDS
  source: hgnc_prev_symbol
  hgnc_symbol: PAFAH1B1
  entrez: '5048'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: DNMT
  symbol: DNMT
  source: hgnc_prev_symbol
  hgnc_symbol: DNMT1
  entrez: '1786'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
chemicals:
- word: Romidepsin
  source: MESH
  identifier: C087123
- word: 5-Azacitidine
  source: MESH
  identifier: D001374
- word: Cytidine
  source: MESH
  identifier: D003562
- word: 'Cytosine  Me '
  source: MESH
  identifier: D003596
- word: Guanine
  source: MESH
  identifier: D006147
- word: Hydralazine
  source: MESH
  identifier: D006830
diseases: []
figid_alias: PMC4559532__F3
redirect_from: /figures/PMC4559532__F3
figtype: Figure
---
